TRICORT 40MGML INJECTION
Riik: Malaisia
keel: inglise
Allikas: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
Toote omadused
(SPC)
17-03-2023
Mõned selle toote dokumendid pole praegu saadaval. Võite saata päringu meie klienditeenindusele ja me teavitame teid sellest niipea, kui meil on neid võimalik hankida.
Saada päring.
Saada päring.
Toimeaine:
TRIAMCINOLONE ACETONIDE
Saadav alates:
PAHANG PHARMACY SDN. BHD.
INN (Rahvusvaheline Nimetus):
TRIAMCINOLONE ACETONIDE
Ühikuid pakis:
1 Vials
Valmistatud:
CADILA PHARM LTD
Toote omadused
BACK SIDE
Pheochromocytoma crisis, which may be fatal, has been reported after
administration of systemic corticosteroids. Corticosteroids
should only be administered to patients with suspected or identified
pheochromocytoma after an appropriate risk/benefit evaluation.
OXXXXXXX
1389, Trasad Road, Dholka-382225,
Dist: Ahmedabad, Gujarat State, India. DATE OF REVISION:
15th March 2023
CO-TREATMENT WITH CYP3A INHIBITORS,
including cobicistat-containing products, is expected to increase the
risk of systemic side-
effects. The combination should be avoided unless the benefit
outweighs the increased risk of systemic corticosteroid side-effects,
in
which case patients should be monitored for systemic corticosteroid
side-effects.
Size : 120 x 400 mm
Export : Malaysia
Pantone P Black C
DG-15/03/23-V06
DG-18/11/22-V05
DG-28/07/22-V04
DG-21/07/22-V03
SS-29/11/18-V02
HV-10/10/16-V01
Lugege kogu dokumenti
